SARS-CoV-2 infection in endothelial cells.
- SARS-CoV-2 likely activates endothelial cell responses in patients which contributes to serious lung symptoms, vascular obstruction and respiratory distress with Covid-19.
- A study shows that endothelial cells which line capillaries lack ACE2 receptors for SARS-CoV-2 attachment and suggests that SARS-CoV-2 indirectly activates endothelial cell linked disease mechanisms that direct coagulation and inflammation associated with severe Covid-19 disease.
- As a result, endothelial cell activation and SARS-CoV-2 induced endothelial cell responses may be potential therapeutic targets to help resolve Covid-19 disease.
For Covid-19 patients with serious lung disease, targeting endothelial cells –cells that comprise the blood vessel wall which regulate oxygen exchange between airways and the bloodstream– may be a novel approach restoring normal lung function. This hypothesis stems from a study by researchers in the Department of Microbiology and Immunology in the Renaissance School of Medicine at Stony Brook University and published in mBio, the leading journal for the American Society for Microbiology.
SARS-CoV-2 causes Covid-19, characterized by pulmonary edema, viral pneumonia, coagulopathy, inflammation and other physiological abnormalities. SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2) receptors to infect and damage ciliated epithelial vascular cells in the upper respiratory tract. Yet how SARS2 dysregulates vascular functions causing an acute respiratory distress syndrome (ARDS) in Covid-19 patients remains an enigma.
Led by Erich Mackow, PhD, a Professor of Microbiology and Immunology, the team of scientists sought to unravel this mechanism by investigating SARS-CoV-2 infection of human endothelial cells from the lung, brain, heart and kidney that are impacted in COVID-19 patients.
“Claims that endothelial cells are infected by SARS-CoV-2 through ACE2 receptors have never been assessed directly,” said Mackow. “Our research revealed that endothelial cells lack ACE2 receptors and that endothelial cells were only SARS-CoV-2 infected after expressing ACE2 receptors in them. Since endothelial cell functions are dysregualted by SARS-CoV-2, these findings suggest a novel mechanism of regulation that does not require viral infection. Instead it suggests the indirect activation of the endothelium, potentially resulting from surrounding tissue damage, that could be the basis for further research to therapeutically target and restore normal endothelial cell responses.”
Mackow adds that their work centers on both endothelial cells and ACE2 functions in Covid-19 disease to identify mechanisms of capillary inflammation and aberrant clotting within vessels. He explains that the research reveals a novel mechanism of clotting and endothelial inflammation observed in the lung and heart of COVID-19 patients.
“A transformative change in the mechanism of endothelial cell dysfunction, not the infection of the cells themselves, changes the way in which disease is initiated and rationales for therapeutic targeting. If endothelial cells are not infected or directly damaged, they can still direct inflammation and clotting by just being activated,” he concludes from the research findings.
The team is working on how endothelial cells can be activated by the virus or in response to other SARS-CoV-2 infected lung cells that express ACE2.
The research suggests the potential to therapeutically target activation, rather than infection of the endothelium, as a strategy for resolving coagulation and inflammatory Covid-19 symptoms.
Mackow emphasizes that additional research of endothelial cells and down-regulated ACE2 functions following SARS-CoV-2 infection are necessary to determine targets that could lead to a reduction in respiratory distress and symptoms of Covid-19 patients.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Endothelial cell targeting
- New Molecular Target Could Result in Cancer Drugs With Fewer Side Effects
New Molecular Target for Cancer Treatment The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) researchers ...
- PDGF: Ophthalmology's Next Great Target
Figure 3 depicts the ischemia-driven upregulation of VEGF, PDGF, FGF and Ang-2 and their target cells (stromal cells, vascular endothelial cells and pericytes). Though PDGFs are closely related to ...
- A New Approach to Treating Heart Diseases
Researchers discover a new way to treat cardiovascular diseases. Vascular and cardiovascular illnesses are greatly influenced by a particular protein found in blood vessel cells. Researchers discovere ...
- Targeting eNOS and Beyond: Emerging Heterogeneity of the Role of Endothelial Rho Proteins in Stroke Protection
Therefore, novel therapeutic paradigms are critically needed that enable more extensive salvage of brain cells ... Targeting eNOS and Beyond: Emerging Heterogeneity of the Role of Endothelial ...
- Targeting Smooth Muscle Protein May Reduce Atherosclerotic Plaque Formation
A new study using mouse models shows that blocking and targeting the protein PERK in smooth muscle cells can decrease the buildup of atherosclerotic plaque by as much as 80%.
Go deeper with Google Headlines on:
Endothelial cell targeting
Go deeper with Bing News on:
Coagulation and inflammatory Covid-19 symptoms
- Retinal Vein Occlusion Associated With COVID Infection
There has been emerging data during the past year indicating coagulation dysfunction predisposing patients with COVID-19 to both arterial and venous thrombotic events,” explains Avni P. Finn, MD. A ...
- What can COVID-19 Teach us about Respiratory Disease?
Until recently, COVID-19 seemed to be a harmless pathogen of minor ... Treatment may require anti-inflammatory therapy, therapy aimed at eliminating coagulation disorders, and, finally, therapy aimed ...
- COVID-19 Test to Treat program is making treatment accessible for everyone
The Pima County Health Department has launched its first COVID-19 Test to Treat program.This allows people who test positive for the virus to receive quick treatment at no cost.
- Substance, Alcohol Abuse Associated with Severe COVID-19 Outcomes
People with a history of a substance or alcohol use disorder are more likely to be hospitalized with a coronavirus disease 2019 (COVID-19) infection, compared to the general public, according to a new ...
- COVID Toes
which occur due to inflammation and long-term exposure to cold air(1 Trusted Source What are some of the unusual symptoms of COVID-19? Ozbey, R., & Algan, M. F. (2022). Acro-ischemic ...